About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 563751, 14 pages
http://dx.doi.org/10.1155/2013/563751
Research Article

A Novel Differential Predict Model Based on Matrix-Assisted Laser Ionization Time-of-Flight Mass Spectrometry and Serum Ferritin for Acute Graft-versus-Host Disease

1Department of Clinical Biochemistry, Chinese PLA General Hospital, 28 Fu-Xing Road, Beijing 100853, China
2Department of Immunology, Nankai University School of Medicine, Tianjin 300071, China
3Department of Hematology, Chinese PLA General Hospital, 28 Fu-Xing Road, Beijing 100853, China

Received 7 May 2013; Accepted 20 August 2013

Academic Editor: Sudhish Mishra

Copyright © 2013 Chun-yan Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bacigalupo, “Acute graft-versus-host disease,” Immunotherapy, vol. 3, no. 12, pp. 1419–1422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Perez, C. Anasetti, and J. Pidala, “Have we improved in preventing and treating acute graft-versus-host disease?” Current Opinion in Hematology, vol. 18, no. 6, pp. 408–413, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Korngold and J. H. Antin, “Biology and management of acute graft-versus-host disease,” Cancer Treatment and Research, vol. 144, pp. 257–275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Toubai, J. Tanaka, S. Paczesny, Y. Shono, P. Reddy, and M. Imamura, “Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD) are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?” Current Stem Cell Research and Therapy, vol. 7, no. 3, pp. 229–239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Socié, “Graft-versus-host disease: proteomics comes of age,” Blood, vol. 113, no. 2, pp. 271–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Paczesny, O. I. Krijanovski, T. M. Braun et al., “A biomarker panel for acute graft-versus-host disease,” Blood, vol. 113, no. 2, pp. 273–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Sakamoto, H. Kawabata, J. Kanda et al., “Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation,” International Journal of Hematology, vol. 97, pp. 109–116, 2013. View at Publisher · View at Google Scholar
  8. G. Kobbe, P. Schneider, U. Rohr et al., “Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody,” Bone Marrow Transplantation, vol. 28, no. 1, pp. 47–49, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. A. R. Rezvani, B. E. Storer, R. F. Storb et al., “Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation,” Biology of Blood and Marrow Transplantation, vol. 17, no. 11, pp. 1594–1601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. L. Tao, Y. Li, J. Gao et al., “Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads,” Journal of Cellular Biochemistry, vol. 113, no. 7, pp. 2268–2278, 2012. View at Publisher · View at Google Scholar
  11. N. Kaneshiro, Y. Xiang, K. Nagai et al., “Comprehensive analysis of short peptides in sera from patients with IgA nephropathy,” Rapid Communications in Mass Spectrometry, vol. 23, no. 23, pp. 3720–3728, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Sivgin, S. Baldane, L. Kaynar et al., “Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation,” Neoplasma, vol. 59, no. 2, pp. 183–190, 2012. View at Publisher · View at Google Scholar
  13. N. S. Majhail, H. M. Lazarus, and L. J. Burns, “Iron overload in hematopoietic cell transplantation,” Bone Marrow Transplantation, vol. 41, no. 12, pp. 997–1003, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Armand, H. T. Kim, C. S. Cutler et al., “Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation,” Blood, vol. 109, no. 10, pp. 4586–4588, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. R. G. Resende, J. D. Correia-Silva, T. A. Silva et al., “Saliva and blood interferon gamma levels and IFNG genotypes in acute graft-versus-host disease,” Oral Diseases, vol. 18, no. 8, pp. 816–822, 2012. View at Publisher · View at Google Scholar
  16. I. Tawara, M. Koyama, C. Liu et al., “Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation,” Clinical Cancer Research, vol. 17, no. 1, pp. 77–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Bouazzaoui, E. Spacenko, G. Mueller et al., “Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease,” Genes and Immunity, vol. 10, no. 8, pp. 687–701, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Aldred, M. M. Grant, and H. R. Griffiths, “The use of proteomics for the assessment of clinical samples in research,” Clinical Biochemistry, vol. 37, no. 11, pp. 943–952, 2004. View at Publisher · View at Google Scholar · View at Scopus